Durá-Travé Teodoro, Gallinas-Victoriano Fidel
Department of Pediatrics, School of Medicine, University of Navarra, Avenue Irunlarrea, 4, 31008 Pamplona, Spain.
Navarrabiomed (Biomedical Research Center), 31008 Pamplona, Spain.
Int J Mol Sci. 2025 May 11;26(10):4593. doi: 10.3390/ijms26104593.
Type 1 diabetes mellitus (T1DM) is a multifactorial disease in which environmental factors and genetic predisposition interact to induce an autoimmune response against pancreatic β-cells. Vitamin D promotes immune tolerance through immunomodulatory and anti-inflammatory functions. The aim of this study is to provide a narrative review about the association between vitamin D status in the pathogenesis of T1DM and the role of vitamin D supplementation in the prevention and treatment of T1DM. Although vitamin D deficiency is more prevalent in children/adolescents with new-onset T1DM than in healthy individuals, there does not appear to be an association between vitamin D status before diagnosis and the onset of T1DMD later in life. The results of vitamin D as adjuvant therapy have, at best, a positive short-term effect in newly diagnosed T1DM patients. Intervention studies have been conducted in the clinical phase of T1DM, but it would be desirable to do so in the early stages of the autoimmune process (pre-diabetes).
1型糖尿病(T1DM)是一种多因素疾病,环境因素和遗传易感性相互作用,引发针对胰腺β细胞的自身免疫反应。维生素D通过免疫调节和抗炎功能促进免疫耐受。本研究的目的是对T1DM发病机制中维生素D状态的关联以及维生素D补充剂在T1DM预防和治疗中的作用进行叙述性综述。尽管维生素D缺乏在新诊断的T1DM儿童/青少年中比在健康个体中更为普遍,但诊断前的维生素D状态与日后发生T1DMD之间似乎并无关联。维生素D作为辅助治疗的结果,对新诊断的T1DM患者充其量只有短期的积极效果。针对T1DM临床阶段开展了干预研究,但在自身免疫过程的早期阶段(糖尿病前期)进行干预研究将更具意义。